Clinical Trial Update: MTX and Steroid for III-IV aGVHD Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating methotrexate and steroid for treatment of acute graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Steroid (steroid)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Graft Versus Host Disease | Phase 2 | Status: UNKNOWN